AMED - Amedisys Non-GAAP EPS of $1.16 beats by $0.18 revenue of $562.06M beats by $1.6M
- Amedisys press release ( NASDAQ: AMED ): Q4 Non-GAAP EPS of $1.16 beats by $0.18 .
- Revenue of $562.06M (+0.5% Y/Y) beats by $1.6M .
- 2023 Guidance
- Adjusted net service revenue is anticipated to be in the range of $2.244 billion to $2.274 billion vs $4.88 consensus.
- Adjusted EBITDA is anticipated to be in the range of $230 million to $240 million.
- Adjusted diluted earnings per share is anticipated to be in the range of $4.13 to $4.36 vs $2.36B consensus based on an estimated 32.9 million shares outstanding.
For further details see:
Amedisys Non-GAAP EPS of $1.16 beats by $0.18, revenue of $562.06M beats by $1.6M